期刊文献+

不同的尿微量蛋白与冠脉病变程度的关系 被引量:4

Association of Different Kinds of Uromicroprotein with Coronary Pathological Change Degree
下载PDF
导出
摘要 目的通过检测冠心病患者尿视黄醇结合蛋白(RBP)、尿微量清蛋白(m-Alb)、尿转铁蛋白(TRF)及尿N-乙酰-β-D氨基葡萄糖苷酶(NAG)的含量,评价尿中4种不同微量蛋白与冠脉病变的关系。方法选取2007年3月—2008年3月上海交通大学医学院附属第九人民医院心内科收治的180例患者,入院后均行冠状动脉造影(CAG),其中135例CAG证实存在冠状动脉狭窄病变者为冠心病组,阴性的45例为非冠心病组。采用酶联免疫吸附法(ELISA)检测各种尿微量蛋白的含量。结果冠心病组和非冠心病组的RBP、m-Alb间差异有统计学意义(P〈0.01)。按CAG结果的Gensini积分方法,积分最低(0~1.0)与积分最高(22.0~)两组的RBP、m-Alb间差异有统计学意义(P〈0.05)。Gensini积分与RBP和NAG均呈正相关,有统计学意义(P〈0.05)。RBP与腰臀比(WHR)、C-反应蛋白(CRP)呈正相关,与高密度脂蛋白胆固醇(HDL-C)呈负相关;m-Alb与WHR、CRP呈正相关,与HDL-C呈负相关;NAG与WHR、CRP呈正相关(P〈0.05)。结论冠心病患者尿微量蛋白含量的增高可能预示着存在冠脉病变;冠脉病变越严重尿微量蛋白含量越多。腹型肥胖者和CRP高者,尿微量蛋白量更高;而HDL-C增高可能是减少尿微量蛋白的一种因素。 Objective To evaluate the association of 4 different kinds of uromicroproteins with the degrees of coronary pathological changes through examining the contents of coronary disease patients' urine retinal binding protein(RBP),urine micro-albumin(m-Alb),urine transferrin(TRF),and urinates N-the acetyl-β-D amino grapeglycosidase(NAG).Methods Totally 180 inpatients presenting from March 2007 to March 2008 in Department of Cardiology,Ninth People's Hospital Affiliated to Shanghai Jiaotong University Medical College were recruited.The coronary angiography(CAG) was performed for all the patients after admission.Among them 135 were diagnosed as having coronary stenosis by CAG(CS group),and 45 had no coronary stenosis(non-CS group).ELISA was taken to examine the contents of uromicroproteins.Results The contents of RBP and m-Alb showed significant difference between the two groups(P0.01).According to the CAG result's Gensini integral method,the lowest integral(0~1.0) group and the highest integral(22.0~) group had significant difference in contents of RBP and m-Alb(P0.05).The Gensini integral was positively correlated with the contents of RBP and NAG(P0.05).The RBP level was correlated positively with the waist to hip ratio(WHR) and C-reactive protein(CRP),negatively with high density lipoprotein-cholesterol(HDL-C);the m-Alb level was correlated with WHR and CRP,negatively with HDL-C;and the NAG level was positively correlated with WHR and CRP(P0.05).Conclusion The increase of uromicroprotein for patients with coronary heart disease may indicate the coronary lesion,and the severer the coronary lesion,the more content the uromicroprotein.The patients with abdominal obesity and high CRP have higher quantity of uromicroprotein;but increase of HDL-C may contribute to reduction of uromicroprotein.
出处 《中国全科医学》 CAS CSCD 北大核心 2011年第19期2153-2155,共3页 Chinese General Practice
关键词 冠状动脉疾病 尿微量蛋白 腰臀比 Coronary artery disease Uromicroprotein Waist-hip ratio
  • 相关文献

参考文献14

  • 1Jensen JS. Microalbuminaria and the risk of atherosclerosis. Clinical epidemiological and physiological investigations [ J ]. Dan Med Bull, 2000, 47 (2): 63-78.
  • 2中国高血压指南修订委员会.中国高血压指南2005修订版[Z].
  • 3Lorenzo C, Haffner SM. Performance characteristics of the new definition of diabetes: the insulin resistance atherescleresis study [ J ]. Diabetes Care, 2010, 33 (2): 335-337.
  • 4中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5215
  • 5Dursunoglu D, Coksoy H, Oztttrk M. A relationship between CRP, adiponectin and C, ensini score in the patients with coronary artery disease [J]. Anadolu Kardiyol Derg, 2011, 11 (3) : 195-200.
  • 6Freedman BI, Langefeld CD, Lohman KK, et al. Relationship between albuminufia and cardiovascular disease in type 2 diabetes [ J]. J Am Soc Nephrol, 2005, 16:2156 -2161.
  • 7Parring HH, Lehnert H, Brochner - Mortensen J, et al. Irbesartan in Patients with Type 2 Diabetes and Mieroalbuminufia Study Group: The effect of irbesartan on the development of diabetic nephropathy in patients with type2 diabetes [J]. N Engl J Med, 2001, 345:870 -878.
  • 8Ruggenenti P, Fassi A, Itieva AP, et al. Bergamo Nephralogic Diabetes Complications Trial ( BENEDICT ) Investigators. Preventing microalbuminuria in type 2 diabetes [J]. N Engl J Med, 2004, 351: 1941 - 1951.
  • 9Ibsen H, Ulsen MH, Wachtell K, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: intervention for endpoint reduction in hypertension study [J ]. Hypertension, 2005, 45:198-202.
  • 10Asselbergs FW, Diercks GF, Hillege HL, et al. Prevention of Renal and Vascular Endstage Disease Intervention Trial ( PBEVEND - IT) Investigators. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria[ J ]. Circulation, 2004, 110: 2809-2816.

二级参考文献149

共引文献5214

同被引文献32

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部